Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Swiss Med Wkly ; 150: w20277, 2020 05 04.
Article in English | MEDLINE | ID: covidwho-2217319

ABSTRACT

In Switzerland, the COVID-19 epidemic is progressively slowing down owing to “social distancing” measures introduced by the Federal Council on 16 March 2020. However, the gradual ease of these measures may initiate a second epidemic wave, the length and intensity of which are difficult to anticipate. In this context, hospitals must prepare for a potential increase in intensive care unit (ICU) admissions of patients with acute respiratory distress syndrome. Here, we introduce icumonitoring.ch, a platform providing hospital-level projections for ICU occupancy. We combined current data on the number of beds and ventilators with canton-level projections of COVID-19 cases from two S-E-I-R models. We disaggregated epidemic projection in each hospital in Switzerland for the number of COVID-19 cases, hospitalisations, hospitalisations in ICU, and ventilators in use. The platform is updated every 3-4 days and can incorporate projections from other modelling teams to inform decision makers with a range of epidemic scenarios for future hospital occupancy.


Subject(s)
Coronavirus Infections , Forecasting/methods , Health Planning/methods , Hospital Bed Capacity , Intensive Care Units/supply & distribution , Pandemics , Pneumonia, Viral , Software , Ventilators, Mechanical/supply & distribution , COVID-19 , Coronavirus Infections/epidemiology , Decision Making, Computer-Assisted , Hospital Bed Capacity/statistics & numerical data , Hospitalization/statistics & numerical data , Hospitalization/trends , Humans , Intensive Care Units/statistics & numerical data , Models, Theoretical , Pandemics/statistics & numerical data , Patient Admission/statistics & numerical data , Pneumonia, Viral/epidemiology , Software/standards , Switzerland/epidemiology , Ventilators, Mechanical/statistics & numerical data
2.
Biomed Res Int ; 2022: 7731618, 2022.
Article in English | MEDLINE | ID: covidwho-1745620

ABSTRACT

While the world continues to grapple with the devastating effects of the SARS-nCoV-2 virus, different scientific groups, including researchers from different parts of the world, are trying to collaborate to discover solutions to prevent the spread of the COVID-19 virus permanently. Henceforth, the current study envisions the analysis of predictive models that employ machine learning techniques and mathematical modeling to mitigate the spread of COVID-19. A systematic literature review (SLR) has been conducted, wherein a search into different databases, viz., PubMed and IEEE Explore, fetched 1178 records initially. From an initial of 1178 records, only 50 articles were analyzed completely. Around (64%) of the studies employed data-driven mathematical models, whereas only (26%) used machine learning models. Hybrid and ARIMA models constituted about (5%) and (3%) of the selected articles. Various Quality Evaluation Metrics (QEM), including accuracy, precision, specificity, sensitivity, Brier-score, F1-score, RMSE, AUC, and prediction and validation cohort, were used to gauge the effectiveness of the studied models. The study also considered the impact of Pfizer-BioNTech (BNT162b2), AstraZeneca (ChAd0x1), and Moderna (mRNA-1273) on Beta (B.1.1.7) and Delta (B.1.617.2) viral variants and the impact of administering booster doses given the evolution of viral variants of the virus.


Subject(s)
Artificial Intelligence , COVID-19/diagnosis , COVID-19/prevention & control , COVID-19/therapy , COVID-19/transmission , Decision Making, Computer-Assisted , Forecasting/methods , Machine Learning , Algorithms , Cohort Studies , Humans , SARS-CoV-2
3.
Eur Rev Med Pharmacol Sci ; 25(6): 2785-2794, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-1173128

ABSTRACT

OBJECTIVE: To develop a deep learning-based decision tree for the primary care setting, to stratify adult patients with confirmed and unconfirmed coronavirus disease 2019 (COVID-19), and to predict the need for hospitalization or home monitoring. PATIENTS AND METHODS: We performed a retrospective cohort study on data from patients admitted to a COVID hospital in Rome, Italy, between 5 March 2020 and 5 June 2020. A confirmed case was defined as a patient with a positive nasopharyngeal RT-PCR test result, while an unconfirmed case had negative results on repeated swabs. Patients' medical history and clinical, laboratory and radiological findings were collected, and the dataset was used to train a predictive model for COVID-19 severity. RESULTS: Data of 198 patients were included in the study. Twenty-eight (14.14%) had mild disease, 62 (31.31%) had moderate disease, 64 (32.32%) had severe disease, and 44 (22.22%) had critical disease. The G2 value assessed the contribution of each collected value to decision tree building. On this basis, SpO2 (%) with a cut point at 92 was chosen for the optimal first split. Therefore, the decision tree was built using values maximizing G2 and LogWorth. After the tree was built, the correspondence between inputs and outcomes was validated. CONCLUSIONS: We developed a machine learning-based tool that is easy to understand and apply. It provides good discrimination in stratifying confirmed and unconfirmed COVID-19 patients with different prognoses in every context. Our tool might allow general practitioners visiting patients at home to decide whether the patient needs to be hospitalized.


Subject(s)
Algorithms , COVID-19/diagnosis , COVID-19/therapy , Decision Trees , Home Care Services/statistics & numerical data , Hospitalization/statistics & numerical data , Aged , COVID-19/epidemiology , COVID-19/virology , COVID-19 Testing , Cohort Studies , Decision Making, Computer-Assisted , Female , Follow-Up Studies , Humans , Italy/epidemiology , Machine Learning , Male , Monitoring, Physiologic , Prognosis , Retrospective Studies , SARS-CoV-2/isolation & purification
5.
SLAS Technol ; 26(2): 123-126, 2021 04.
Article in English | MEDLINE | ID: covidwho-1004312

ABSTRACT

Artificial intelligence (AI) plays a major role in addressing novel coronavirus 2019 (COVID-19)-related issues and is also used in computer-aided synthesis planning (CASP). AI, including machine learning, is used by artificial neural networks such as deep neural networks and recurrent networks. AI has been used in activity predictions like physicochemical properties. Machine learning in de novo design explores the generation of fruitful, biologically active molecules toward expected or finished products. Several examples establish the strength of machine learning or AI in this field. AI techniques can significantly improve treatment consistency and decision making by developing useful algorithms. AI is helpful not only in the treatment of COVID-19-infected patients but also for their proper health monitoring. It can track the crisis of COVID-19 at different scales, such as medical, molecular, and epidemiological applications. It is also helpful to facilitate the research on this virus by analyzing the available data. AI can help in developing proper treatment regimens, prevention strategies, and drug and vaccine development. Combination with synthesis planning and ease of synthesis are feasible, and more and more automated drug discovery by computers is expected in the near future to eradicate the COVID-19 virus.


Subject(s)
Artificial Intelligence , COVID-19 , Decision Making, Computer-Assisted , SARS-CoV-2 , Algorithms , COVID-19/diagnosis , COVID-19/prevention & control , COVID-19/therapy , Humans , Neural Networks, Computer
6.
Comput Math Methods Med ; 2020: 9391251, 2020.
Article in English | MEDLINE | ID: covidwho-751442

ABSTRACT

In this paper, a utility-based multicriteria model is proposed to support the physicians to deal with an important medical decision-the screening decision problem-given the squeeze put on resources due to the COVID-19 pandemic. Since the COVID-19 emerged, the number of patients with an acute respiratory failure has increased in the health units. This chaotic situation has led to a deficiency in health resources. Thus, this study, using the concepts of the multiattribute utility theory (MAUT), puts forward a mathematical model to aid physicians in the screening decision problem. The model is used to generate which of the three alternatives is the best one for where patients with suspected COVID-19 should be treated, namely, an intensive care unit (ICU), a hospital ward, or at home in isolation. Also, a decision information system, called SIDTriagem, is constructed and illustrated to operate the mathematical model proposed.


Subject(s)
Betacoronavirus , Clinical Laboratory Techniques/statistics & numerical data , Coronavirus Infections/diagnosis , Pandemics , Pneumonia, Viral/diagnosis , COVID-19 , COVID-19 Testing , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Critical Care , Decision Making, Computer-Assisted , Decision Support Techniques , Home Care Services , Hospitalization , Humans , Mass Screening , Mathematical Concepts , Monte Carlo Method , Patient Isolation , Pneumonia, Viral/epidemiology , Pneumonia, Viral/therapy , SARS-CoV-2 , Triage/methods
SELECTION OF CITATIONS
SEARCH DETAIL